Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mathiesen

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Neurology|December 2, 2010
Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patientsY Isayev, E Conahan, C Mathiesen, et al.
Lakartidningen|November 10, 1993
[Why not more than one general practitioner?]J V Larsen, C Mathiesen, L Kumlin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Homoeostatic response criteria for cancer therapyE Hippe, V Jønsson, H von der Maase, et al.
Neuropsychologia|November 12, 2015
The effects of tDCS upon sustained visual attention are dependent on cognitive loadJames M Roe, Mathias Nesheim, Nina C Mathiesen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activityE O Nielsen, T Varming, C Mathiesen, et al.
Brain and Behavior|November 16, 2016
Age-related differences in brain network activation and co-activation during multiple object trackingErlend S Dørum, Dag Alnæs, Tobias Kaufmann, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Neurology|December 2, 2010
Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patientsY Isayev, E Conahan, C Mathiesen, et al.
Lakartidningen|November 10, 1993
[Why not more than one general practitioner?]J V Larsen, C Mathiesen, L Kumlin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Homoeostatic response criteria for cancer therapyE Hippe, V Jønsson, H von der Maase, et al.
Neuropsychologia|November 12, 2015
The effects of tDCS upon sustained visual attention are dependent on cognitive loadJames M Roe, Mathias Nesheim, Nina C Mathiesen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activityE O Nielsen, T Varming, C Mathiesen, et al.
Brain and Behavior|November 16, 2016
Age-related differences in brain network activation and co-activation during multiple object trackingErlend S Dørum, Dag Alnæs, Tobias Kaufmann, et al.
Pageof 2